Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton …

E Wronska, M Polkowski, J Orlowska, A Mroz… - …, 2021 - thieme-connect.com
Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …
被引用次数：20 相关文章

Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton …

E Wronska, M Polkowski, J Orlowska, A Mroz… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …

Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton …

E Wronska, M Polkowski, J Orlowska, A Mroz… - Endoscopy, 2020 - europepmc.org
Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …

Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton …

E Wronska, M Polkowski, J Orlowska, A Mroz… - …, 2021 - thieme-connect.com
Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …